ILT-2 Antibodies

Santa Cruz Biotechnology offers a broad range of ILT-2 monoclonal antibodies for research focused on understanding immune regulation mechanisms. ILT-2 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ILT-2, also known as LILRB1, is an immune checkpoint receptor that plays a critical role in regulating immune responses and maintaining tolerance. By interacting with major histocompatibility complex (MHC) class I molecules, ILT-2 modulates the activity of immune cells, influencing both innate and adaptive immunity. Understanding the function of ILT-2 is essential for developing therapeutic strategies in cancer and autoimmune diseases. Researchers can explore ILT-2's role in various cellular pathways and signaling mechanisms using specific detection methods. Advanced imaging techniques and protein analysis methods reveal important details about ILT-2's cellular distribution and molecular interactions. Investigating ILT-2's involvement in immune cell regulation can lead to breakthrough discoveries in immunology. Santa Cruz Biotechnology monoclonal antibodies support cutting-edge research that advances our understanding of immune system regulation and potential therapeutic applications.